Progenity's Transformation: Your Guide to Biora Therapeutics
Quick Summary
- Progenity rebranded to Biora Therapeutics
- Genetic testing services discontinued
- Focus now on oral biotherapeutics
The company formerly known as Progenity, Inc., a biotechnology firm recognized for its advancements in molecular testing for women's health and gastrointestinal conditions, has undergone a significant corporate transformation. This strategic shift led to the divestiture of its laboratory business and a rebranding to Biora Therapeutics, Inc.. The focus has now moved towards pioneering oral biotherapeutics and developing innovative ingestible devices for precise drug delivery and diagnostic sampling. If you are searching for information about Progenity, its services, or your past patient portal access, it is crucial to understand this evolution. This guide will help clarify the current status of the former Progenity offerings and direct you to relevant information concerning the company's new identity and how this transition impacts previous services. The original mission was to improve diagnoses and patient outcomes, a goal now pursued through advanced therapeutic platforms.
- 📋 Understanding the Legacy of Progenity's Healthcare Offerings
- 📍 Navigating Access to Former Progenity Patient Data
- ⭐ Exploring Progenity's Historical Diagnostic Services
- ⚠️ Addressing Inquiries for Past Progenity Services
- 🔒 Ensuring Data Privacy from Previous Progenity Operations
- 🎧 Official Help Desk Contacts
- ❓ Clarifying Key Questions About Progenity's Evolution
Understanding the Legacy of Progenity's Healthcare Offerings
- To understand Progenity's former healthcare offerings, it's important to recognize its previous role as a biotechnology company focused on molecular diagnostic tests. These tests aimed to provide actionable information during critical life stages, such as family planning and pregnancy.
- The company's initial vision involved transforming healthcare through precise and personal molecular testing products, utilizing a multi-omics approach.
- For inquiries regarding results from its discontinued genetic tests, patients might need to reference their original test order information, dates of service, and any documentation received at the time of testing.
Navigating Access to Former Progenity Patient Data
- The patient portal previously offered by Progenity, Inc. for accessing genetic test results was part of its former laboratory business.
- Following the company's strategic transformation and rebranding to Biora Therapeutics, Inc., the original patient portal for these genetic testing services is no longer actively managed by the rebranded entity in the same capacity.
- Patients seeking historical genetic test results should not expect to log into a live 'Progenity' portal, but instead inquire with Biora Therapeutics or any successor laboratory that may have acquired patient data from the divested lab operations.
- For new information or current services, individuals should refer to Biora Therapeutics as the successor company. The official link for the rebranded entity is www.bioratherapeutics.com.
Exploring Progenity's Historical Diagnostic Services
- Historically, Progenity, Inc. developed and commercialized molecular testing products in women's health and gastrointestinal health.
- Its offerings included genetic laboratory-developed tests such as the Preparent® Carrier Test, Innatal® Prenatal Screen, Riscover® Hereditary Cancer Test, and Resura® Prenatal Test.
- A successful patient portal was developed to allow customers convenient online access to sensitive test results.
- Post-transformation, the entity now known as Biora Therapeutics is focused on developing a suite of investigational ingestible devices designed for precise diagnostic sampling and targeted drug delivery solutions, particularly for gastrointestinal health and oral biotherapeutics.
Addressing Inquiries for Past Progenity Services
⚠️ Cannot access my Progenity patient portal or old test results
Cause: Progenity, Inc. has rebranded to Biora Therapeutics, Inc. and has exited its genetic laboratory business, discontinuing many former test services. The original patient portal for genetic results is no longer active under the Progenity name by the rebranded company.
Solution: We understand that accessing past health information is important. As Progenity's lab business was divested, any inquiries regarding historical genetic test results should be directed to the successor company, Biora Therapeutics, or potentially the laboratory that acquired Progenity's assets. You may find updated contact information on the Biora Therapeutics website or in official communications related to the divestiture. For general inquiries during the transition, older investor relations contacts were available.
Ensuring Data Privacy from Previous Progenity Operations
- 🔒 Following the divestiture of its lab business, data handling for past Progenity genetic tests would be subject to agreements made during the sale of assets to other entities.
- 🔒 Always ensure you are on a legitimate website when attempting to access any health information. Look for HTTPS in the web address and a padlock icon in your browser.
- 🔒 Be cautious of unsolicited communications asking for personal health information. Legitimate medical providers will follow established security protocols for data sharing.
- 🔒 For current operations, Biora Therapeutics, the successor to Progenity, adheres to stringent data privacy standards as a biotechnology company. Any patient data retained or transferred would be managed in compliance with applicable regulations.
🎧 Official Support & Help Center
For general investor or media inquiries during the transition, previous contacts included [email protected] or (917) 741-7792. For current inquiries related to Biora Therapeutics, please visit their official website for updated contact information.
Clarifying Key Questions About Progenity's Evolution
Q: What happened to Progenity, Inc.?
Progenity, Inc. underwent a strategic transformation, exiting its genetic laboratory business and rebranding to Biora Therapeutics, Inc. The company now focuses on developing oral biotherapeutics and ingestible devices.
Q: How do I get my old Progenity test results?
Since Progenity discontinued its genetic testing services and sold its laboratory business, the original patient portal may no longer be active. You should contact Biora Therapeutics, the rebranded entity, for guidance on accessing historical results. Information regarding the transfer of patient records would have been part of the divestiture process.
Q: Did Progenity stop offering genetic tests?
Yes, Progenity, Inc. announced a strategic transformation that included discontinuing its genetic laboratory-developed test services, such as the Preparent® Carrier Test and Innatal® Prenatal Screen.
Q: What is Biora Therapeutics?
Biora Therapeutics, Inc. is the new name for the company formerly known as Progenity, Inc. It is a biotechnology company focused on gastrointestinal health and oral biotherapeutics, developing ingestible devices for drug delivery and diagnostic sampling.
Wrap Up
The journey of Progenity, Inc. to Biora Therapeutics, Inc. represents a significant pivot in its corporate strategy, moving from molecular diagnostics to advanced biotherapeutics. While past patient services like genetic testing and associated portals have ceased under the Progenity name, the new entity, Biora Therapeutics, continues to innovate within the healthcare space. Understanding this transformation is key for anyone seeking information related to the former Progenity brand or its services.